Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia
Rossana Maffei(Azienda Ospedaliero-Universitaria di Modena), Roberto Marasca(University of Modena and Reggio Emilia)
Cited by 56
Related Papers
Bone Marrow Failure Associated with Human Herpesvirus 8 Infection after Transplantation
|New England Journal of Medicine|2000|242
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
|Blood|2015|215
Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival
|Journal of Clinical Oncology|2014|210
Three cases of human herpesvirus‐6 latent infection: Integration of viral genome in peripheral blood mononuclear cell DNA
|Journal of Medical Virology|1993|175